The team, from biopharmaceutical company Regeneron, hopes their work will help researchers better understand protein-protein interactions during preclinical development of a drug. “Essentially, we ...
This breakthrough has accelerated peptide drug development across multiple therapeutic areas, including cardiovascular ...
Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks. Cells ...
Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...
The Innovation Center of NanoMedicine (iCONM, Center Director: Prof. Kazunori Kataoka) is pleased to announce that research conducted by a group led by Shingo Ueno, Deputy Principal Research Scientist ...
Researchers from Canada and the United States have created an artificial intelligence (AI) tool called PepMLM to target “undruggable” disease proteins. This development could lead to new treatments ...
Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole (receptor) formed by a protein's three-dimensional structure and a molecule ...
Researchers have developed a deep-learning model, called PepFlow, that can predict all possible shapes of peptides -- chains of amino acids that are shorter than proteins, but perform similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results